Fusion Family Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6
Closed -$2K 43
2021
Q1
$2K Hold
6
﹤0.01% 98
2020
Q4
$1K Hold
6
﹤0.01% 93
2020
Q3
$2K Sell
6
-11
-65% -$3.07K ﹤0.01% 93
2020
Q2
$5K Sell
17
-10
-37% -$3.01K ﹤0.01% 89
2020
Q1
$9K Buy
27
+21
+350% +$6.37K ﹤0.01% 87
2019
Q4
$2K Sell
6
-89
-94% -$24.7K ﹤0.01% 123
2019
Q3
$22K Buy
95
+31
+48% +$7.22K 0.01% 88
2019
Q2
$15K Buy
64
+58
+967% +$13.4K ﹤0.01% 107
2019
Q1
$1K Sell
6
-58
-91% -$18.3K ﹤0.01% 141
2018
Q4
$19K Sell
64
-150
-70% -$47.9K 0.01% 159
2018
Q3
$76K Buy
214
+208
+3,467% +$71.6K 0.02% 98
2018
Q2
$2K Hold
6
﹤0.01% 254
2018
Q1
$2K Hold
6
﹤0.01% 241
2017
Q4
$2K Hold
6
﹤0.01% 254
2017
Q3
$2K Hold
6
﹤0.01% 198
2017
Q2
$2K Hold
6
﹤0.01% 247
2017
Q1
$2K Sell
6
-124
-95% -$35.1K ﹤0.01% 264
2016
Q4
$37K Buy
+130
New +$38.5K 0.02% 142

Other funds holding BIIB

Fusion Family Wealth's BIIB Position: Q2 2021 in Review

Fusion Family Wealth sold out of Biogen (BIIB) in Q2 2021, closing a stake of 6 shares — an estimated $2K sold.

Fusion Family Wealth first reported a position in BIIB in Q4 2016 and held it in 18 quarters. The position peaked at $76K in Q3 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Fusion Family Wealth reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Fusion Family Wealth sold 6 Biogen shares in Q2 2021, an estimated $2K.
  • Fusion Family Wealth first reported a position in Biogen in Q4 2016 and held it in 18 quarters.
  • Fusion Family Wealth's Biogen position peaked at $76K in Q3 2018.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Fusion Family Wealth's 13F filing for Q2 2021, filed 30 Jul 2021.